Name: Military DMSS Data Leak Reveals Disease Runs Rampant In the U.S. Military After Being Vaccinated
Uploaded: 2022-01-29T05:36:55+00:00
Duration: 6 min 42 s
Description: On January 25, 2022, Thomas Renz, the attorney for Doctors Peter Chambers, Theresa Long, and Samuel Sigoloff, testified before Congress regarding data leak directly from the Defense Health Agencies De

2 years ago

6.92K

Military Pandemic Adverse Reactions

On January 25, 2022, Thomas Renz, the attorney for Doctors Peter Chambers, Theresa Long, and Samuel Sigoloff, testified before Congress regarding data leak directly from the Defense Health Agencies Defense Medical Epidemiology Database, otherwise known as DMED. Within DMED exists the Defense Medical Surveillance System’s DMSS, which contains up to date and historic data on diseases, medical events, and data on DoD personnel. The database is similar to VAERS, the vaccine adverse event reporting system, but it’s distinct in that it only applies to DoD military personnel and only medical providers can input information into the system. Upon inspection, we can see that information has been gathered from a five year average of dozens of diseases and medical disorders.

The current data reflects diseases in 2021 through the tenth month only. All data reflects reporting from January through November 2021. Annual cases are average over the past five years.

Myocardial Infarction / Heart Attack heart rose 269% from 612 annual cases to YTD 1,650.

Pericarditis rose 175% from 589 annual cases to YTD 1,029.

Myocarditis rose 285% from 127 annual cases to YTD 363.

Pulmonary embolisms 467% from 746 annual cases to YTD 3,489,

Cerebral infarction rose 393% with current YTD 3,438.

Bell’s Palsy rose 319% with current YTD 1,470.

Guillain-Barre Syndrome rose 250% with current YTD 3,635.

Immunodeficiencies rose 275% with current YTD 3,172.

Immune Thrombocytopenic Purpura rose 322% with current YTD 564.

Menstrual Irregularity rose 476% with current YTD 22,938.

Multiple Schlerosis / Demyelinating Diagnosis rose 487% with current YTD 3,444 .

Neoplasms (tissue growth, often cancer precursor) rose 296% with current YTD 114,645.